ICH/EMA: Adoption of the ICH M15 guideline on general principles for model-informed drug development
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
This guideline defines an harmonised framework for evaluating MIDD evidence and provides recommendations for related planning and regulatory interactions, implementation, reporting, and submission. In the rapidly evolving landscape of drug development, model-informed drug development (MIDD) evidence is playing an increasingly crucial role in guiding decisions made by drug developers, regulatory authorities, and other key stakeholders. To streamline the assessment of this valuable evidence, ...
Fields of Study & Subjects
Pharmaceutical studies and practices
Statistical Methods in Clinical Trials
Pharmacogenetics and Drug Metabolism
Publication details
- Journal / source
- Hypotheses (OpenEdition)
- Publication date
- 28 March 2026
- Language
- EN